Iowa State geneticist Jeffrey Essner will lead a four-year, $3 million project to develop gene editing methods for animals in concert with ag-bio firm Recombinetics.
US National Institutes of Health will be examining its grant-awarding process for bias against African Americans, ScienceInsider reports.
The company said its new genetic variation analysis and visualization system will help provide clinicians with a more efficient way to make decisions about patient care.
University of Copenhagen researchers will examine the possibility of using next-generation sequencing to reconstruct the genomes of ancient and extinct species.
Researchers plan to develop a device that supports nucleic acid sequencing and protein sequencing using plasmonic nanostructures.
The VP lauded the work of the assembled researchers, offered suggestions for ways forward, and asked for their help in determining how to change the system for the better.
The center has invited experts to consider how technologies like CRISPR/Cas9 and mitochondrial replacement will affect values held by various groups.
As part of the effort, Virus.X also aims to craft new sequencing approaches, bioinformatics tools, and targeted gene products.
The Biotec Pharmacon subsidiary is taking part in the Virus-X EU Consortium by developing new viral enzymes and bringing them to the market.
The Horizon 2020 grant will help the Israeli firm commercially develop its noninvasive DNA methylation-based tests for cancer screening and monitoring.
Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.
The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.
Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.
In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.